TFF Pharmaceuticals, Inc. Common Stock
TFFP
TFFP was delisted on the 12th of December, 2024.
3 hedge funds and large institutions have $0 invested in TFF Pharmaceuticals, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
25% less funds holding
Funds holding: 4 → 3 (-1)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less capital invested
Capital invested by funds: $196 → $0 (-$196)
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SS
SBI Securities
Tokyo,
Japan
|
-$196 |
TFFP Hedge Fund Activity: Q1 2025 in Review
3 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in TFF Pharmaceuticals, Inc. Common Stock (TFFP) for Q1 2025, worth a combined $0 — down 100% from $196 a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of TFFP and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was SBI Securities, exiting entirely with an estimated $196 sold.
- 3 institutional investors held TFF Pharmaceuticals, Inc. Common Stock (TFFP) as of Q1 2025, down from 4 in Q4 2024.
- Funds reported $0 of TFF Pharmaceuticals, Inc. Common Stock stock for Q1 2025, down 100% quarter-over-quarter.
- 1 fund opened new TFF Pharmaceuticals, Inc. Common Stock positions in Q1 2025 and 2 closed out, a net change of -1 holder.
- The largest TFF Pharmaceuticals, Inc. Common Stock seller in Q1 2025 was SBI Securities, an estimated $196 sold.
Based on aggregated 13F filings for Q1 2025.